The Fox Chase Chemical Diversity Center Announces it Has Been Awarded an NIH Grant from the National Institution of Aging Entitled “Therapeutics Targeting TDP-43 to Treat Alzheimer’s Disease and Related Disorders”
Doylestown, PA. June 25, 2021 – FCCDC is pleased to announce that it was been awarded a grant from the National Institution of Aging of the National Institutes of Health entitled “Therapeutics targeting TDP-43 to treat Alzheimer’s disease and related disorders” (U01AG068823).